BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

738 related articles for article (PubMed ID: 32962159)

  • 1. The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance.
    Mola S; Pandolfo C; Sica A; Porta C
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32962159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-Associated Macrophages (TAMs) in Colorectal Cancer (CRC): From Mechanism to Therapy and Prognosis.
    Wang H; Tian T; Zhang J
    Int J Mol Sci; 2021 Aug; 22(16):. PubMed ID: 34445193
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The heterogeneity of tumour-associated macrophages contributes to the clinical outcomes and indications for immune checkpoint blockade in colorectal cancer patients.
    Tang J; Ming L; Qin F; Qin Y; Wang D; Huang L; Cao Y; Huang Z; Yin Y
    Immunobiology; 2024 May; 229(3):152805. PubMed ID: 38669865
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ST2 as checkpoint target for colorectal cancer immunotherapy.
    Van der Jeught K; Sun Y; Fang Y; Zhou Z; Jiang H; Yu T; Yang J; Kamocka MM; So KM; Li Y; Eyvani H; Sandusky GE; Frieden M; Braun H; Beyaert R; He X; Zhang X; Zhang C; Paczesny S; Lu X
    JCI Insight; 2020 May; 5(9):. PubMed ID: 32376804
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Wnt5a-induced M2 polarization of tumor-associated macrophages via IL-10 promotes colorectal cancer progression.
    Liu Q; Yang C; Wang S; Shi D; Wei C; Song J; Lin X; Dou R; Bai J; Xiang Z; Huang S; Liu K; Xiong B
    Cell Commun Signal; 2020 Mar; 18(1):51. PubMed ID: 32228612
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut microbiota-stimulated cathepsin K secretion mediates TLR4-dependent M2 macrophage polarization and promotes tumor metastasis in colorectal cancer.
    Li R; Zhou R; Wang H; Li W; Pan M; Yao X; Zhan W; Yang S; Xu L; Ding Y; Zhao L
    Cell Death Differ; 2019 Nov; 26(11):2447-2463. PubMed ID: 30850734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolic dysfunction and early-onset colorectal cancer - how macrophages build the bridge.
    Scheurlen KM; Billeter AT; O'Brien SJ; Galandiuk S
    Cancer Med; 2020 Sep; 9(18):6679-6693. PubMed ID: 33624450
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumor-associated macrophages in colorectal cancer metastasis: molecular insights and translational perspectives.
    Hou S; Zhao Y; Chen J; Lin Y; Qi X
    J Transl Med; 2024 Jan; 22(1):62. PubMed ID: 38229160
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Role of the Gut Microbiome in Colorectal Cancer: Where Are We? Where Are We Going?
    Wieczorska K; Stolarek M; Stec R
    Clin Colorectal Cancer; 2020 Mar; 19(1):5-12. PubMed ID: 31678050
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic Reprogramming of Colorectal Cancer Cells and the Microenvironment: Implication for Therapy.
    Nenkov M; Ma Y; Gaßler N; Chen Y
    Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34200820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Streptococcus bovis Contributes to the Development of Colorectal Cancer via Recruiting CD11b⁺TLR-4⁺ Cells.
    Deng Q; Wang C; Yu K; Wang Y; Yang Q; Zhang J; Xu X
    Med Sci Monit; 2020 Aug; 26():e921886. PubMed ID: 32737964
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor Infiltrating Regulatory T Cells in Sporadic and Colitis-Associated Colorectal Cancer: The Red Little Riding Hood and the Wolf.
    Fantini MC; Favale A; Onali S; Facciotti F
    Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32937953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of tumor-infiltrating immune cells in relation to microbiota in colorectal cancers.
    Kikuchi T; Mimura K; Ashizawa M; Okayama H; Endo E; Saito K; Sakamoto W; Fujita S; Endo H; Saito M; Momma T; Saze Z; Ohki S; Shimada K; Yoshimura K; Tsunoda T; Kono K
    Cancer Immunol Immunother; 2020 Jan; 69(1):23-32. PubMed ID: 31768581
    [TBL] [Abstract][Full Text] [Related]  

  • 14. MicroRNAs: Novel immunotherapeutic targets in colorectal carcinoma.
    Li X; Nie J; Mei Q; Han WD
    World J Gastroenterol; 2016 Jun; 22(23):5317-31. PubMed ID: 27340348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-associated macrophages employ immunoediting mechanisms in colorectal tumor progression: Current research in Macrophage repolarization immunotherapy.
    Cheruku S; Rao V; Pandey R; Rao Chamallamudi M; Velayutham R; Kumar N
    Int Immunopharmacol; 2023 Mar; 116():109569. PubMed ID: 36773572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis.
    Wei C; Yang C; Wang S; Shi D; Zhang C; Lin X; Liu Q; Dou R; Xiong B
    Mol Cancer; 2019 Mar; 18(1):64. PubMed ID: 30927925
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeting tumor-associated macrophages as an antitumor strategy.
    Cheng N; Bai X; Shu Y; Ahmad O; Shen P
    Biochem Pharmacol; 2021 Jan; 183():114354. PubMed ID: 33279498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The Ap-2α/Elk-1 axis regulates Sirpα-dependent tumor phagocytosis by tumor-associated macrophages in colorectal cancer.
    Wang X; Luo X; Chen C; Tang Y; Li L; Mo B; Liang H; Yu S
    Signal Transduct Target Ther; 2020 Apr; 5(1):35. PubMed ID: 32296015
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Peptostreptococcus anaerobius promotes colorectal carcinogenesis and modulates tumour immunity.
    Long X; Wong CC; Tong L; Chu ESH; Ho Szeto C; Go MYY; Coker OO; Chan AWH; Chan FKL; Sung JJY; Yu J
    Nat Microbiol; 2019 Dec; 4(12):2319-2330. PubMed ID: 31501538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Infiltration of CD204-overexpressing Macrophages Contributes to the Progression of Stage II and III Colorectal Cancer.
    Tada Y; Matsumi Y; Hara K; Miyauchi W; Sugesawa K; Uejima C; Tanio A; Kihara K; Yamamoto M; Takano S; Sakamoto T; Nakayama Y; Hasegawa T; Fujiwara Y
    Anticancer Res; 2021 Oct; 41(10):4857-4865. PubMed ID: 34593433
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.